Alpha Compute Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tortola
SEC filing record 1 source field available
Fiscal year end
31 March
Alpha Compute Corp has filed 772 SEC EDGAR filings since 01 Aug 2000

SEC filing history

Showing 351-375 of 602 matching filings.

Per page
25
Current page
15
6-K File 000-30314

FDA CLEARS BIOHAVEN'S IND FOR BHV-4157 ANS PORTAGE TO HOLD INVESTOR CONFERENCE C

Filing date
07 Jul 2016
Reporting date
05 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE ANNOUNCES ORPHAN DRUG DESIGNATION REQUEST GRANTED FTO BIOHAVEN FOR BHV 4

Filing date
26 May 2016
Reporting date
26 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN APPOINTS CHIEF COMMERCIAL OFFICER

Filing date
27 Apr 2016
Reporting date
27 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE PROVIDES CORPORATE UPDATES

Filing date
07 Apr 2016
Reporting date
07 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE INVESTS FURTHER IN BIOHAVEN

Filing date
23 Mar 2016
Reporting date
23 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

ORPHAN DRUG DESIGNATION RECEIVED BY BIOHAVEN

Filing date
21 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

ANNOUNCEMENT OF PROPOSED PRIVATE PLACEMENT

Filing date
14 Mar 2016
Reporting date
14 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

THIRD QUARTER 16 FINANCIALS AND MDA

Filing date
26 Feb 2016
Reporting date
26 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

EXPEDITED DEVELOPMENT PATH FOR BHV 0223 FOR BIOHAVEN

Filing date
25 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

POSITIVE RESULTS FROM PHASE 1 STUDY WITH BHV-0223

Filing date
25 Feb 2016
Reporting date
25 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

NOTICE OF RECORD AND MAILING DATE

Filing date
08 Feb 2016
Reporting date
08 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE PROVIDES PPL UPDATES

Filing date
25 Jan 2016
Reporting date
25 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

INTERIM FINANCIALS FOR THE SIX MONTHS ENDED SEPT 30, 2015

Filing date
01 Dec 2015
Reporting date
27 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN PHASE 1 TRIALS

Filing date
23 Nov 2015
Reporting date
23 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN COMPLETES MULTIPLE DOSING IN PHASE ONE TRIAL

Filing date
06 Oct 2015
Reporting date
06 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

STRATEGIC ALLIANCE WITH FOX CHASE CHEMICAL

Filing date
02 Oct 2015
Reporting date
02 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN COMPLETES SINGLE DOSE PHASE

Filing date
21 Sep 2015
Reporting date
21 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE ISSUES LETTER TO SHAREHOLDERS

Filing date
21 Sep 2015
Reporting date
18 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PPL ADVANCES ITS PPL-003 TO AN IND

Filing date
31 Aug 2015
Reporting date
31 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN DOSES FIRST HUMAN SUBJECT IN PHASE 1 TRIAL

Filing date
27 Aug 2015
Reporting date
27 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

QUARTERLY FINANCIALS AND MDA 6.30.2015

Filing date
26 Aug 2015
Reporting date
26 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORTAGE BIOHAVEN INDA GETS CLEARANCE FORM FDA

Filing date
25 Aug 2015
Reporting date
25 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN ACQUIRES NEW IPS

Filing date
21 Aug 2015
Reporting date
21 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

BIOHAVEN RAISES $4.1

Filing date
11 Aug 2015
Reporting date
11 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 000-30314

PORATGE INVESTS IN SENTIEN

Filing date
11 Aug 2015
Reporting date
11 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .